Covered recipient · General Payments record
ELISE APRIL STROBEL CHONG
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2018–2024
$31,906.85
- Reported across 48 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $4,990.00 | 2 |
| Travel and Lodging | $937.91 | 4 |
| Food and Beverage | $209.12 | 7 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $2,740.00 | 1 |
| BeiGene USA, Inc. | $2,250.00 | 1 |
| Genmab U.S., Inc. | $1,107.27 | 10 |
| ADC Therapeutics America, Inc. | $39.76 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (13)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ADC Therapeutics America, Inc. | $39.76 | 12/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1121185426 | CMS |
| AstraZeneca Pharmaceuticals LP | $2,740.00 | 03/05/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105620363 | CMS |
| BeiGene USA, Inc. | $2,250.00 | 04/04/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1120849444 | CMS |
| Genmab U.S., Inc. | $856.95 | 11/07/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1126826254 | CMS |
| Genmab U.S., Inc. | $29.21 | 11/08/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1126826250 | CMS |
| Genmab U.S., Inc. | $28.00 | 11/08/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1126826252 | CMS |
| Genmab U.S., Inc. | $23.75 | 11/08/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1126826256 | CMS |
| Genmab U.S., Inc. | $55.20 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126826258 | CMS |
| Genmab U.S., Inc. | $18.30 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126826260 | CMS |
| Genmab U.S., Inc. | $6.14 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126826262 | CMS |
| Genmab U.S., Inc. | $28.19 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126826264 | CMS |
| Genmab U.S., Inc. | $28.19 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126826266 | CMS |
| Genmab U.S., Inc. | $33.34 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126826268 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.